PDCD1 and hepatocellular carcinoma: Taken together, our study suggested that upregulation of circulating PD-1/PD-L1 could serve as novel valid immunological markers in predicting disease progression of HCC patients after cryoablation; and this would be helpful for the improved clinical management and the development of new therapeutic options for patient with HBV-related HCC.